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Abstract
The 23rd Annual Meeting of the European Tissue Repair Society, Reims, France, October 23 to 25, 2013 focused on
tissue repair and regenerative medicine covering topics such as stem cells, biomaterials, tissue engineering, and
burns.
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Introduction
The 23rd Annual Meeting of the European Tissue Repair
Society (ETRS) was organized by Jean-Jacques Lataillade
and Bernard Coulomb in the Reims Congress Center,
Reims, France from 23 to 25 October 2013 (Figure 1).
The 189 attendees included clinical, industrial, and basic
scientists, of which 54 were students. Eighteen countries
were represented, several from outside of Europe (USA,
Australia, Canada, Japan, South Korea, and Mexico).
The general theme “Stem cells and regenerative medi-
cine”, continued the tradition of previous meetings to
join with local societies. Seven of the 10 sessions were
organized in association with French research and clin-
ical societies: “Scar and reconstructive surgery” (Société
Française et Francophone des Plaies et Cicatrisation),
“Cardiovascular repair”, “Matrix and Biofilm” (Société
Française de la Biologie de la Matrice ExtraCellulaire),
“Burns” (Société Française de Traitement et d’Etude de
la Brûlure), “Biomaterials” (Association pour le dévelop-
pement des Biomatériaux), “Stem cell niche and rejuven-
ation”, “Cell and tissue engineering” (Société Française
de Bio-ingénierie Cellulaire et Tissulaire). The European
Wound Management Association guest session was ded-
icated to infection.
The French Societies also contributed to the 10 awards
for Young Investigators, this year adding up to 3.500€.
The ETRS award for the best oral presentation, which
includes an invitation to the 2014 Annual Meeting of
the Wound Healing Society (WHS) in Orlando, Florida,
was won by Raya Bushkalova (Inserm, Toulouse, France).
Her winning presentation was entitled “Polyelectrolyte
scaffolds for cardiac mesenchymal stem cell therapy”.
The interaction with the WHS was reinforced by the
attendance of Paul Liu (WHS President) and Bob Diegel-
mann (WHS past President) together with a total of 13
attendees from the United States. The Australasian
Wound & Tissue Repair Society (AWTRS) was also
well-represented by 4 active members including Allison
Cowin (AWTRS past President), giving the opportunity
to strengthen the exchange between the societies. Inter-
action with industry was fostered through 5 “Industrial
Forums” (Healthpoint, Laboratoires Brothier, Maco-
Pharma, Médicen, and Terumo BCT) and lively ex-
changes at the exhibition stands. Finally, 75 posters were
presented during the meeting. The following sections will
give an overview of the scientific content of the meeting.
Abstracts of the contributions have been published else-
where [Wound Repair Regen 2013, 21:A55-A88].
Dynamics and consequences of the inflammatory
response in tissue repair and regeneration
Evidence from different model organisms indicates that
the immune system is of primary importance in determin-
ing the outcome of the repair response, including the
extent of scarring as well as the restoration of organ struc-
ture and function. Yet, the functional relationship between
repair, regeneration, and the immune response is complex
and not completely understood. In this year’s Charles
Lapière Memorial Lecture, Sabine Eming outlined positive
and negative roles of the immune response in tissue
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Figure 1 Flyer of the 23rd Annual Meeting of the European Tissue Repair Society.
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repair. Her group contributed substantially to the molecu-
lar understanding of the consequences of an unbalanced
inflammatory response at the wound site, leading to pro-
found effects on downstream cell activities essential for re-
pair. Recent data from murine wound models have
identified monocytes/macrophages as critical regulators of
distinct functions during the sequential stages of wound
healing. This indicates their potential for monocyte-based
therapies in tissue repair, and supports current clinical
studies that investigate monocyte/macrophage activation
to normalize tissue homeostasis. In future studies, it will
be important to further dissect the beneficial and harmful
effects of the inflammatory response during wound healing.
The vascular system: from cardiovascular repair to
endothelial cell heterogeneity
Human pluripotent stem cells hold great promise in regen-
erative medicine. However, their differentiation towards
mature cells such as functional cardiomyocytes remains a
major challenge. A novel protocol was presented, based on
epicardium-derived cells and a 3-dimensional collagen
scaffold that allows the differentiation of cardiac progenitor
cells to functional cardiomyocytes capable to regenerate a
failing myocardium. Another group presented further
insight in signaling pathways, including Notch and hypoxia
inducible factor that direct endothelial cell heterogeneity,
which might have consequences for diseases affecting
different parts of the vascular system. These findings
can be used to generate vascular bed-specific endothe-
lial cells from endothelial progenitor cells in revasculari-
zation therapies.
Cellular senescence
Cellular senescence or progressive exhaustion of cell
proliferation was described for the first time more than
50 years ago by Dr. Hayflick. Today, we differentiate be-
tween replicative and stress-induced cellular senescence.
Both are caused by damage to DNA via the p53/p21CIP1
and p16INK4A/pRB pathways, which might be related to
atherosclerosis, osteoarthritis, and chronic cutaneous
wounds. It was also emphasized that senescence may be
a tumor suppressive mechanism. Although senescence-
associated β-galactosidase activity is used as a marker, it
can only be applied to cryopreserved tissue. At the con-
ference, lipofucin was presented as a potentially more
versatile biomarker that can be detected in archival
paraffin-embedded tissue.
In 2012, Professor Yamanaka received the Noble Prize
for reprogramming adult human dermal fibroblasts into
induced pluripotent stem cells (iPSCs) using a 4-factor
cocktail (Oct4, Sox2, Klf4, c-Myc). Novel data discussed
at the meeting showed that it is also possible to repro-
gram senescent cells into iPSCs using a 6-factor cocktail.
Cell therapy
More than 500 companies are involved in the develop-
ment of cell therapies worldwide. Culture systems for
somatic stem cells are becoming more sophisticated in re-
capitulating the in vivo conditions. It was emphasized that
3-dimensional matrices in bioreactors will improve the
yield of the desired cell phenotype. There is also a trend of
replacing animal-derived serum components with mito-
genic human platelet lysate. In addition, the inclusion of
endothelial cells in the tissue constructs might increase
the grafting success.
The current status of adipose stem cell therapy in vari-
ous areas of regenerative medicine was reviewed at the
meeting. Interestingly, initial trials indicate that is pos-
sible to isolate adipose-derived stem cell-like cells from
burn eschar. This source of stem cells may prove useful
in the treatment of burn injuries. In addition, a new
therapeutic strategy was presented in the use of autolo-
gous keratinocytes in treating patients with burn injuries
(Figure 2).
Developments in biomaterials and tissue
engineering
Bone and cartilage are tissues that the field of tissue
engineering and regenerative medicine has since long
investigated. A keynote presentation focused on the
communication between mesenchymal stem cells (MSCs)
and endothelial progenitor cells in bone engineering, and
its importance for obtaining a 3-dimensional vascularized
tissue. Niche factors also determine the fate of stem cells.
An interesting development is the high-throughput screen-
ing of biochemical and biophysical niche factors. For ex-
ample, type I collagen microspheres impregnated with
transforming growth factor-β3 and seeded with MSCs
form a cartilage-like tissue in culture. Also in vivo, the
Figure 2 Human keratinocyte clones within a human
mesenchymal stem cell feeder layer. KC: keratinocytes, MSC:
mesenchymal stem cell.
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microspheres induced cartilaginous tissue after subcutane-
ous implantation in mice. Chitosan/hydroxyapatite matri-
ces and coral scaffolds cultured in a perfusion bioreactor
might be suitable for bone engineering. Also, human am-
niotic membrane was shown to have osteogenic potential
in vitro as well as in vivo.
Further presentations focused on the engineering of
less intensively studied tissues. Recent advances in the
generation of red blood cells for blood transfusion show
that human embryonic stem cells and iPSCs can be used
for this purpose. Gingival mucosa injuries exhibit nearly
scarless healing and thereby resembling fetal tissue heal-
ing mechanisms. Gingival fibroblasts were shown to
have an even higher capacity than dermal fibroblasts to
promote healing in several wound models. Also in the
field of oral tissue engineering, a new model for muscle
regeneration in the soft palate of the rat was presented.
This model may be applied in the development of new
strategies to improve the healing of surgical wounds
after cleft palate repair.
Biofilm and infection
A keynote lecture explained that biofilms are communities
of microorganism that are attached to a surface, with the
cells encased in extracellular polymeric substance, typically
composed of polysaccharides, proteins, extracellular DNA,
and lipids. Biofilm is a virulence factor and especially
common in severe infections that are difficult to eradi-
cate. Aggressive surgical debridement is paramount in
these cases. Negative pressure wound therapy is a useful
supplement of lower limb infections. In traumatic cases,
negative pressure therapy combined with an antiseptic
has proven to be especially effective against osteomyelitis.
Interestingly, osteomyelitis can be induced experimentally
with methicillin-resistant Staphylococcus aureus (MRSA)
biofilm applied to open fractures.
Pressure ulcers are often neglected but can be a risk
factor for MRSA infection. Therefore, close attention
should be paid to the microbiological status of these
chronic wounds. The cornerstone in the treatment of in-
fected pressure ulcers is surgical debridement. The use
of antibiotics should be restricted to cases of sepsis and
osteomyelitis to avoid resistance.
Conclusion
The 23rd Annual Meeting of the European Tissue Repair
Society provided an exciting update of new develop-
ments in crucial areas of both fundamental and clinical
aspects of wound healing and tissue repair. This meeting
underlined that several stem cell protocols have already
been developed into treatments in humans demonstrat-
ing that stem cell-based regenerative medicine may be
translated into therapies in patients with wound heal-
ing problems. The meeting created a lively forum for
interactions between professionals from different disci-
plines, thus reflecting the mission statement of the
ETRS: “…to promote knowledge and interchange be-
tween scientists, healthcare professionals, industry and
other individuals that have an interest in tissue repair
of all organs”. The 24rd Annual Meeting of the ETRS
will take place in Edinburgh (UK) from September 11–13,
2014, and the 7th Joint Meeting of the ETRS & the WHS
in Copenhagen (Denmark) October 20–22, 2015.
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